The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
Roger S McIntyreRoger Nelson RodriguesOrly LipsitzFlora NasriHartej GillLeanna Mw LuiMehala SubramaniapillaiKevin KratiukKayla TeopizRoger HoYena LeeRodrigo B MansurJoshua D RosenblatPublished in: Journal of psychopharmacology (Oxford, England) (2020)
Patients with TRD and prominent anxiety receiving IV ketamine exhibited a significant reduction in depressive, SI and anxiety symptoms.